Harry A. Rogoff
- Molecular Biology top 10%
- Oncology top 5%
- Cancer Research top 10%
- Epidemiology
- Toxicology top 2%
- Co-authors
- Chiang J. LiTimothy F. KowalikMary PickeringManish A. ShahWěi LiXiangao SunYouzhi LiDavid Leggett
- Topics
- Cancer-related Molecular Pathways (6 papers)Cancer Cells and Metastasis (4 papers)Bioactive Compounds and Antitumor Agents (3 papers)
- Cited by
- ToxicologyOncologyCancer Research
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical OncologyNature Biotechnology
- Partner nations
- United StatesSpainSweden
In The Last Decade
Harry A. Rogoff
21 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Molecular Biology 746
- Oncology 525
- Cancer Research 243
- Epidemiology 108
- Toxicology 106
Countries citing papers authored by Harry A. Rogoff
This map shows the geographic impact of Harry A. Rogoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry A. Rogoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry A. Rogoff more than expected).
Fields of papers citing papers by Harry A. Rogoff
This network shows the impact of papers produced by Harry A. Rogoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry A. Rogoff. The network helps show where Harry A. Rogoff may publish in the future.
Co-authorship network of co-authors of Harry A. Rogoff
This figure shows the co-authorship network connecting the top 25 collaborators of Harry A. Rogoff. A scholar is included among the top collaborators of Harry A. Rogoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry A. Rogoff. Harry A. Rogoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 84 | |
| 2 | 22 | |
| 3 | 58 | |
| 4 | 6 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 8 | |
| 8 | 2 | |
| 9 | Suppression of cancer relapse and metastasis by inhibiting cancer stemnessbreakdown → | 382 |
| 10 | 1 | |
| 11 | 23 | |
| 12 | 91 | |
| 13 | 94 | |
| 14 | 44 | |
| 15 | 41 | |
| 16 | 59 | |
| 17 | 103 | |
| 18 | 27 | |
| 19 | 90 | |
| 20 | 3 |
About Harry A. Rogoff
Harry A. Rogoff is a scholar working on Toxicology, Oncology and Cancer Research, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (6 papers), Cancer Cells and Metastasis (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). The work is most often cited by research in Toxicology (106 citations), Oncology (525 citations) and Cancer Research (243 citations). Harry A. Rogoff has collaborated with scholars based in United States, Spain and Sweden. Frequent co-authors include Chiang J. Li, Timothy F. Kowalik, Mary Pickering, Manish A. Shah, Wěi Li, Xiangao Sun, Youzhi Li, David Leggett, Sarah Keates and Yuan Gao. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.